Tel：+86-18874232226 WhatsApp：+86-18874232226 E-mail：lisa@qankorey.com

About Qankorey

→

About Qankorey

Hunan Qankorey Biotechnology Co., Ltd.

Founded in 2014, Qankorey is headquartered in Changsha, Hunan Province, China. As a biotechnology enterprise, Qankorey focuses on researching key technologies for Alzheimer's Disease (AD)—a globally recognized major medical challenge.

Boasting its own R&D center in Melbourne, Australia, Qankorey has established collaborations with leading Australian research institutions, including the Florey Institute of Neuroscience & Mental Health, as well as the Australian Biomarker & Imaging Lifestyle Flagship Study of Aging (AIBL)—the world’s largest longitudinal consortium dedicated to AD research. Over the years, Qankorey has also partnered with a number of renowned domestic tertiary hospitals and institutions. Together, they work to advance the translation of scientific and technological achievements in geriatric disease prevention and treatment into market applications, while building an international exchange platform that integrates scientific research with clinical practice.

Committed to independent innovation, Qankorey has appointed Prof. Baijun Gu—an internationally acclaimed brain neuroscientist and founder of the Natural Phagocytosis Theory—as its Chief Scientist, and assembled a high-caliber international research team. Deeply rooted in the AD field, Qankorey has built a full-industry-chain R&D layout covering AD prevention, prediction, intervention, and treatment, with its core focus on the company’s independently developed Aβ monoclonal antibody. To date, the company has secured over 160 intellectual property rights, including more than 10 international patents filed under the Patent Cooperation Treaty (PCT).

Looking ahead, Qankorey will continue to fulfill its mission of delivering comprehensive AD solutions to patients and their families worldwide through technological innovation. It will focus on developing a one-stop integrated solution for AD and other forms of dementia, with the ultimate goal of helping the elderly live healthier, longer lives.

Company Culture

Through scientific and technological innovation, we provide a full range of Alzheimer's solutions for patients and families around the world, focus on core technologies, integrate global resources, and continue to innovate to serve public health!

Company Value

Concentric dedication innovation beyond integrity and efficiency

Company Vision

Global AD Ecosystem Service Provider

Company Mission

Care for the Health of the Elderly Guarding the Memory of Love